LeMaitre Vascular (LMAT), a provider of peripheral vascular devices and implants, announced that on 17 September 2014 it acquired the angioscope product line from Applied Medical for $420,000.

Last 12 months’ sales of the device are estimated to be $360,000. Angioscopes are fiberoptic catheters that allow visualization of the interior of peripheral arteries and veins.

They are commonly used to assess vein quality or confirm valve lysis during peripheral bypass, the procedure in which the HYDRO LeMaitre Valvulotome is used.

"This tuck-in acquisition adds to our sales bag a valuable diagnostic tool that complements our #1 product line," said David Roberts, President of LeMaitre Vascular. "We anticipate a smooth integration."

In conjunction with the acquisition, Applied Medical will provide manufacturing transition services from its production facility in Orange County, CA for up to one year.

LeMaitre Vascular is a provider of devices for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide.

The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.